Reuters: Health
AstraZeneca Plc said on Wednesday it had received marketing authorization from China's National Medical Products Administration for its top-selling drug, Tagrisso, to treat adults with a form of lung cancer.
AstraZeneca's Tagrisso gets China OK for type of lung cancer
AstraZeneca's Tagrisso gets China OK for type of lung cancer
Reuters: Health
AstraZeneca Plc said on Wednesday it had received marketing authorization from China's National Medical Products Administration for its top-selling drug, Tagrisso, to treat adults with a form of lung cancer.
Reuters: Health
AstraZeneca Plc said on Wednesday it had received marketing authorization from China's National Medical Products Administration for its top-selling drug, Tagrisso, to treat adults with a form of lung cancer.
Subscribe to:
Post Comments (Atom)
Popular Posts
|
No comments:
Post a Comment